男子遭误诊坐43年轮椅,50多岁重学走路:不恨医院

2016-09-26 刘惠莉_BJS2866 环球时报-环球网(北京)

9月25日报道,一名葡萄牙男子13岁时遭误诊,致使其随后的43年都在轮椅上度过,一直到近60岁才重新学会走路。报道称,该男子名叫博雷戈(Rufino Borrego),13岁时被里斯本一家医院诊断出患有无法治愈的肌肉萎缩症。于是,他开始了漫长的轮椅生涯。直到2010年,一名神经科医生发现,他其实只是患上一种罕见的“肌无力症”,只要服用治哮喘的药物就可以治愈。而此时,博雷戈已经在轮椅上度过了43年。

9月25日报道,一名葡萄牙男子13岁时遭误诊,致使其随后的43年都在轮椅上度过,一直到近60岁才重新学会走路。



报道称,该男子名叫博雷戈(Rufino Borrego),13岁时被里斯本一家医院诊断出患有无法治愈的肌肉萎缩症。于是,他开始了漫长的轮椅生涯。

直到2010年,一名神经科医生发现,他其实只是患上一种罕见的“肌无力症”,只要服用治哮喘的药物就可以治愈。而此时,博雷戈已经在轮椅上度过了43年。服药治疗一年后,博雷戈就已经能够正常走路了。

据悉,现年61岁的博雷戈除了每年须要接受两次物理治疗之外,目前已经能够正常生活。

他称自己并没有怨恨误诊的医院,并指出在上世纪60年代,医学界对肌无力症的认识不足。他说:“我现在只想充分利用每一天。”


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1673184, encodeId=663016e318433, content=<a href='/topic/show?id=8c0a926556e' target=_blank style='color:#2F92EE;'>#走路#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92655, encryptionId=8c0a926556e, topicName=走路)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54d126929591, createdName=cqlidoudou, createdTime=Fri Feb 17 23:36:00 CST 2017, time=2017-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=135533, encodeId=dc4813553308, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Sep 26 20:10:15 CST 2016, time=2016-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=135532, encodeId=20b71355325c, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Sep 26 20:10:04 CST 2016, time=2016-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=135501, encodeId=edf51355017d, content=在国内老早大打出手了,国外医患关系太和平了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd381919282, createdName=1e0a2178m68(暂无匿称), createdTime=Mon Sep 26 19:26:27 CST 2016, time=2016-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=135488, encodeId=d7a11354885e, content=放在中国,哈哈!大发啦!, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=118f1734484, createdName=1def5ef1m18(暂无匿称), createdTime=Mon Sep 26 18:42:46 CST 2016, time=2016-09-26, status=1, ipAttribution=)]
    2017-02-17 cqlidoudou
  2. [GetPortalCommentsPageByObjectIdResponse(id=1673184, encodeId=663016e318433, content=<a href='/topic/show?id=8c0a926556e' target=_blank style='color:#2F92EE;'>#走路#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92655, encryptionId=8c0a926556e, topicName=走路)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54d126929591, createdName=cqlidoudou, createdTime=Fri Feb 17 23:36:00 CST 2017, time=2017-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=135533, encodeId=dc4813553308, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Sep 26 20:10:15 CST 2016, time=2016-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=135532, encodeId=20b71355325c, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Sep 26 20:10:04 CST 2016, time=2016-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=135501, encodeId=edf51355017d, content=在国内老早大打出手了,国外医患关系太和平了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd381919282, createdName=1e0a2178m68(暂无匿称), createdTime=Mon Sep 26 19:26:27 CST 2016, time=2016-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=135488, encodeId=d7a11354885e, content=放在中国,哈哈!大发啦!, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=118f1734484, createdName=1def5ef1m18(暂无匿称), createdTime=Mon Sep 26 18:42:46 CST 2016, time=2016-09-26, status=1, ipAttribution=)]
    2016-09-26 知难而进

    谢谢分享!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1673184, encodeId=663016e318433, content=<a href='/topic/show?id=8c0a926556e' target=_blank style='color:#2F92EE;'>#走路#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92655, encryptionId=8c0a926556e, topicName=走路)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54d126929591, createdName=cqlidoudou, createdTime=Fri Feb 17 23:36:00 CST 2017, time=2017-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=135533, encodeId=dc4813553308, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Sep 26 20:10:15 CST 2016, time=2016-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=135532, encodeId=20b71355325c, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Sep 26 20:10:04 CST 2016, time=2016-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=135501, encodeId=edf51355017d, content=在国内老早大打出手了,国外医患关系太和平了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd381919282, createdName=1e0a2178m68(暂无匿称), createdTime=Mon Sep 26 19:26:27 CST 2016, time=2016-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=135488, encodeId=d7a11354885e, content=放在中国,哈哈!大发啦!, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=118f1734484, createdName=1def5ef1m18(暂无匿称), createdTime=Mon Sep 26 18:42:46 CST 2016, time=2016-09-26, status=1, ipAttribution=)]
    2016-09-26 知难而进

    继续关注!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1673184, encodeId=663016e318433, content=<a href='/topic/show?id=8c0a926556e' target=_blank style='color:#2F92EE;'>#走路#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92655, encryptionId=8c0a926556e, topicName=走路)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54d126929591, createdName=cqlidoudou, createdTime=Fri Feb 17 23:36:00 CST 2017, time=2017-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=135533, encodeId=dc4813553308, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Sep 26 20:10:15 CST 2016, time=2016-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=135532, encodeId=20b71355325c, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Sep 26 20:10:04 CST 2016, time=2016-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=135501, encodeId=edf51355017d, content=在国内老早大打出手了,国外医患关系太和平了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd381919282, createdName=1e0a2178m68(暂无匿称), createdTime=Mon Sep 26 19:26:27 CST 2016, time=2016-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=135488, encodeId=d7a11354885e, content=放在中国,哈哈!大发啦!, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=118f1734484, createdName=1def5ef1m18(暂无匿称), createdTime=Mon Sep 26 18:42:46 CST 2016, time=2016-09-26, status=1, ipAttribution=)]
    2016-09-26 1e0a2178m68(暂无匿称)

    在国内老早大打出手了,国外医患关系太和平了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1673184, encodeId=663016e318433, content=<a href='/topic/show?id=8c0a926556e' target=_blank style='color:#2F92EE;'>#走路#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92655, encryptionId=8c0a926556e, topicName=走路)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54d126929591, createdName=cqlidoudou, createdTime=Fri Feb 17 23:36:00 CST 2017, time=2017-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=135533, encodeId=dc4813553308, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Sep 26 20:10:15 CST 2016, time=2016-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=135532, encodeId=20b71355325c, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Sep 26 20:10:04 CST 2016, time=2016-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=135501, encodeId=edf51355017d, content=在国内老早大打出手了,国外医患关系太和平了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd381919282, createdName=1e0a2178m68(暂无匿称), createdTime=Mon Sep 26 19:26:27 CST 2016, time=2016-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=135488, encodeId=d7a11354885e, content=放在中国,哈哈!大发啦!, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=118f1734484, createdName=1def5ef1m18(暂无匿称), createdTime=Mon Sep 26 18:42:46 CST 2016, time=2016-09-26, status=1, ipAttribution=)]
    2016-09-26 1def5ef1m18(暂无匿称)

    放在中国,哈哈!大发啦!

    0

相关资讯

治疗ED药物有望缓解罕见病杜兴氏肌肉萎缩症症状

杜兴氏肌肉萎缩症(Duchene muscular dystrophy,简称“DMD”)是一种由抗肌萎缩蛋白基因缺陷引起的罕见遗传疾病。抗肌萎缩蛋白水平不足使一氧化氮的功能受到抑制,而一氧化氮是人在运动时血液正常流入肌肉所必需的一种化学物质。全球每 3600 名男童中就有 1 人患这种疾病,而女童则极少受其影响。这种疾病可引起极严重的症状,包括行走或抬臂能力逐渐丧失、心肌及呼吸系统功能衰弱、认知功

Nat Commun:移植干细胞有望治疗肌肉萎缩症

日本研究人员在最新一期英国《自然-通讯》杂志上报告说,他们发现了两种能够促进骨骼肌再生的小核糖核酸,添加了小核糖核酸的骨骼肌干细胞被植入患有肌肉萎缩症的动物体内,可成功实现骨骼肌的再生。 肌肉萎缩症是一种损坏人体肌肉的遗传性疾病。由于身体无法制造支撑肌肉结构的蛋白质,患者会变得无法运动。目前几乎没有有效的治疗方法。 骨骼肌具有非常高的再生能力,即使由于激烈的运动受到损伤或者

JCI:新型小鼠模型为肌肉萎缩症治疗提供思路

肌肉萎缩症(muscular dystrophy)是一种比较复杂的遗传性疾病,遗传突变可以改变几种不同的蛋白质的功能,而这些蛋白质可以形成一种复合物,这种复合物却是连接肌肉细胞和细胞外基质(ECM)之间的“结构大桥”。在病人中,这种遗传突变所引发的效应非常广泛,为了开发出新型的疗法,研究者需要特定的动物模型来精确在其体内表现出人类疾病的状况和疾病发病过程。 近日,刊登在国际杂志the Journ

科学家深入了解毁灭性肌肉萎缩症致病机理

恶病质是疗养机构常见的一种病症,比如图中法国普都市的这个病例。图片来源:Voisin 如果可以重来一次,我不会再把时间花费在西米布丁上,而是会花更多时间告诉妻子我爱她 作为一名疗养研究员,Susan McClement曾和很多弥留之际的癌症患者及其家人交流过,他们的一些故事深深地印刻在她的脑海中。一名男子的妻子因受转移性乳腺癌的折磨而极为憔 悴,他于是强迫妻子进食,当她

STM:修复蛋白被激活帮助肌肉萎缩症患者生成肌肉细胞

当肌肉细胞膜遭到破坏,修复蛋白质dysferlin就会被激活并且重新帮助生成肌肉细胞膜。如果这种修复蛋白质由于基因突变被改变,那么人体自身的“质量控制”系统(即蛋白酶体)就认为该蛋白质是缺陷的继而消除它。如果没有dysferlin蛋白,那么受伤的肌肉细胞膜就不能被修复,从而导致骨骼肌细胞逐渐损失最终致使肌肉萎缩。看来,人体自身的“质量控制体系"会中和突变蛋白质dysferlin,即使这种突变

PNAS:修改肌营养相关蛋白治疗肌肉萎缩症

  在美国大约有250,000人患有肌营养不良症,三年前,密苏里州大学科学家们发现了一个分子化合物,对治疗疾病是至关重要的,但他们不知道如何使化合物结合肌肉细胞。在一项新的发表在PNAS杂志上的研究中,MU学校医学院科学家Yi Lai和Dongsheng Duan已经解决了部分难题,最终可能导致出现潜在的治疗疾病策略。   杜氏进行性肌营养不良症(DMD)主要影响男性,是最常